12 results
424B3
SYRS
Syros Pharmaceuticals Inc.
8 Aug 22
Prospectus supplement
5:47pm
/prospectus, SM-88 drug substance is being manufactured by a FDA registered and inspected third party and to date that manufacturer is Tyme’s sole supplier … of this drug substance. Tyme believes that replacement for this supplier, in the event it becomes necessary, is not impossible, but would cause Tyme
S-4
SYRS
Syros Pharmaceuticals Inc.
18 Jul 22
Registration of securities issued in business combination transactions
7:58am
sole supplier of this drug substance. Tyme believes that replacement for this supplier, in the event it becomes necessary, is not impossible … supplier for this drug substance.
Third parties may hold IP rights that impact, restrict or inhibit manufacturing or sale of a commercial version of any
425
SYRS
Syros Pharmaceuticals Inc.
5 Jul 22
Business combination disclosure
7:14am
or service providers for the sole purpose of enabling such supplier or service providers to provide services for Tyme’s benefit).
(e) Tyme has delivered … and business data, pricing and cost information, business and marketing plans and customer and supplier lists and information, whether patentable
8-K
EX-10.4
SYRS
Syros Pharmaceuticals Inc.
5 Jul 22
Syros to Raise Approximately $190 Million Through Merger with TYME Technologies and Concurrent Private Placement
7:07am
subsidiaries, or with the employees of any principal supplier, manufacturer, customer or contractor of the Company or any of its subsidiaries, exists
8-K
EX-2.1
SYRS
Syros Pharmaceuticals Inc.
5 Jul 22
Syros to Raise Approximately $190 Million Through Merger with TYME Technologies and Concurrent Private Placement
7:07am
licensed to suppliers or service providers for the sole purpose of enabling such supplier or service providers to provide services for Tyme’s benefit).
(e … , financial, marketing and business data, pricing and cost information, business and marketing plans and customer and supplier lists and information, whether
8-K
EX-10.1
h72j23ho3q cm4yi1
13 Oct 21
Departure of Directors or Certain Officers
4:01pm
8-K
EX-2.1
la0ksr9w
7 Dec 20
Entry into a Material Definitive Agreement
6:05am
8-K
EX-10.1
tpfs34ayyf1r 4mm09u
7 Dec 20
Entry into a Material Definitive Agreement
6:05am
10-K
EX-10.12
1k1yfqo04 chcc
20 Mar 17
Annual report
12:00am
- Prev
- 1
- Next